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the protease in cerebellar granule cells and
its regulation by the apoptosis-inhibiting
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Abstract
Background: Apoptosis takes place in naturally occurring neuronal death, but also in aging, neurodegenerative
disorders, and traumatic brain injuries. Caspase 3 (Casp3) is the most important effector protease in apoptosis:
being inactive inside the cell, it undergoes enzymatic cleavage and - hence - activation once the apoptotic cascade
is triggered. Immunological techniques with antibodies against cleaved Casp3 (cCasp3) or assays with colorimetric/
fluorogenic substrates are commonly in use, but they do not allow to directly follow the dynamics of activation in
alive neurons that may be committed to die.
Results: By combined biolistic transfection, confocal microscopy, and fluorescence resonance energy transfer
(FRET), we have implemented a methodology to dynamically monitor Casp3 activation in organotypic cerebellar
slices from postnatal mice. After transfection with pSCAT3 FRET probes, we measured the ratio of the emissions of
the donor/acceptor pair (ECFPem/Venusem) in fixed or alive cultures. In so doing, we i. discriminated the cellular
compartment(s) of enzyme activation (nucleus, perikaryon, neurites); ii. demonstrated that Casp3 was constitutively
active in the granule cells; iii. followed the fluctuations of ECFPem/Venusem, and its response to 25 mM KCl
depolarization, or to increased intracellular Ca++ after NMDA (1 mM), kainic acid (1 mM), or A23187 (100–200 μM).
The specificity of the active pSCAT3-DEVD probe was confirmed with RNA interference and after inhibition of Casp3
with Ac-DEVD-CMK (100 μM), as both sets of experiments brought ECFPem/Venusem to the values recorded with the
control probe pSCAT3-DEVG. After double-transfection with pSCAT3-DEVD + pHcRed1-C1-survivin, we also showed
a 44–56 % reduction of basal Casp3 activity in cells overexpressing survivin, a protein-member of the family of
apoptosis inhibitors, with augmented survival (2.82 folds). Survivin-rescued cells were sensitive to 5 mM H2O2
oxidative stress but died without intervention of Casp3.
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Conclusions: This ex vivo FRET-based methodology provides quantitative information on the functional and
histological dynamics of Casp3 activation in individual neurons at a cell level resolution. Not only it can be
combined with experimental manipulation of the apoptotic machinery inside the cell, but offers several advantages
over existing protocols for monitoring apoptosis in live mammalian neurons, and has potential to be transferred
in vivo. Due to the pivotal role of Casp3 in apoptosis, our approach is relevant for a better comprehension of
molecular neurodegeneration in the normal and pathological brain.
Keywords: Neurons, Caspase 3, Survivin, Apoptosis, FRET, Biolistic transfection, Cerebellum, Organotypic cultures,
Live imaging, Confocal microscopy
Background
Apoptosis is a well-known form of programmed cell
death (PCD), the apoptotic program being triggered at
genomic level and leading to specific biochemical and
ultrastructural cellular alterations [1]. The term naturally
occurring neuronal death (NOND) was coined to high-
light the physiological role of PCD in the maturation of
neurons and their connections [2]. However, apoptosis is
also responsible for neurodegeneration and neuronal
loss in aging, neurodegenerative disorders and traumatic
brain injuries [1].
Caspases are a family of related proteases playing sev-
eral important functions in apoptosis. They are essential
to completion of PCD [3–5], and are activated in a cas-
cade leading to rapid disablement of key cell structural
proteins, chromatin condensation and DNA fragmenta-
tion, cell shrinkage and blebbing [6].
Caspase 3 (Casp3) is the most important executioner cas-
pase [7, 8]: it is ubiquitous in inactive form, but becomes
enzymatically cleaved in apoptotic cells that thus harbor
the active protease (cleaved Casp3 - cCasp3) [9]. It is there-
fore not surprising that significant efforts have been de-
voted to the development of specific assays to monitor
Casp3 activity in tissues and cells. Production of specific
antibodies has been a major breakthrough [10], but im-
munocytochemistry (ICC), ELISA, or Western blotting,
and assays with colorimetric or fluorogenic substrates do
not allow a direct analysis of Casp3 activation dynamics
during cell death and/or in response to cellular stressors.
To overcome such a limitation, alternative approaches have
been sought for. For example, in the past we have used the
ApoAlert™ pcaspase3-sensor vector to analyze the cleavage
of Casp3 in the course of cerebellar NOND [11]. This ap-
proach, however, was not amenable to quantitative studies,
and thus of limited value for further pharmacological
characterization. Likewise, others have used different types
of functionalized probes for optical imaging of Casp3 in iso-
lated neurons or in the intact brain and retina after
experimentally-induced apoptosis [12–15].
The bulk of studies on Casp3 activation have been car-
ried out in vitro, using primary neurons and/or neuronal
cell lines. These approaches offer good opportunities to
unravel the intervention of the protease in neuronal
PDC, allowing to pharmacologically challenge homoge-
neous cell populations, and to easily investigate cause-
to-effect correlations. However, they do not obviously
permit analysis of the interplay between different types
of neurons, or neurons and glia. Yet the study of NOND
in vivo is challenging, and substantial difficulties need to
be faced when tackling it. Most important are the asyn-
chrony of the process, which, within the same brain
area, affects several different types of neurons at differ-
ent times; its close relationship with proliferation; and
the very rapid clearance of apoptotic cells from tissue by
the microglia [10]. Despite of these difficulties, observa-
tions in intact animals not only have shown that the
cerebellar granule cells (CGCs) - the most abundant type
of cortical neurons in cerebellum - undergo an apoptotic
type of NOND shortly after their generation, but also
that some underlying molecular mechanisms are differ-
ent in CGC progenitors/precursors or fully differentiated
CGCs [16].
Brain organotypic slices represent an optimal tool for
analysis of NOND and experimentally-induced neuronal
death ex vivo, as reviewed in [17]. We here describe a
methodology to study Casp3 activation in organotypic
cerebellar cultures (OCCs) by the combination of
biolistic transfection, laser scanning confocal fluores-
cence microscopy (LSCFM), and fluorescence resonance
energy transfer (FRET). LSCFM allows exciting small
spatial volumes with submicron resolution, to provide
different simultaneous readouts (intensity, spectral char-
acteristics), and to measure fluorescence emissions from
different channels in the same tissue volume [18]. Here
used in combination with FRET, a technology that enables
detecting protein-to-protein interactions in living cells
[19], LSCM not only permitted the visualization of Casp3
activity in individual neurons, but also yielded quantitative
information about the dynamics of protease activation. In
addition, we implemented a double-transfection protocol
to demonstrate the interplay between Casp3 and survivin,
a critically required protein for survival of developing
CNS neurons that also intervenes in neural repair, and
neurodegeneration [20].
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Results and discussion
Transfection of OCCs
According to the experimental need, OCCs were trans-
fected with plasmids encoding any of the following fluores-
cent reporter proteins (FRPs): enhanced cyan fluorescent
protein (ECFP) – cyan emission; green fluorescent protein
(GFP) – green emission; the Venus variant of yellow fluor-
escent protein (YFP) – yellow emission; and wild-type Dis-
cosoma red fluorescent protein (DsRed1), humanized
(HcRed1) – red emission. Starting from twenty-four hours
post-transfection (HPT), fluorescent cells were easily spot-
ted in OCCs with appropriate filter combinations (wide-
field fluorescence microscopy) or excitation/emission
settings (LSCFM). The peak of FRP expression was
achieved around forty-eight to seventy-two HPT. Subse-
quently, neither there was an obvious increase/reduction of
fluorescence intensity in individual cells, nor in the number
of fluorescent cells, but FRPs were still detectable in cul-
tures maintained in vitro up to two weeks. Although num-
bers were variable, from several tens up to a few hundreds
of successfully transfected neurons/slice were yielded after
a single Gene Gun® shot (Fig. 1a).
Biolistic transfection of murine OCCs with plasmid
cDNAs using the human cytomegalovirus (hCMV) as a
promoter, for the most tagged the CGCs [21]. In keeping
with these previous observations, successfully transfected
neurons were easily identified as post-mitotic CGCs in the
course of axonogenesis [22] on the basis of their morph-
ologies (Fig. 1b-g), mean size (see also Specificity of the
pSCAT3 probe for Casp3), and after combined ICC with
the specific marker NeuN [23] (Fig. 1h). We carried out
all FRET measurements on these cells at 48 HPT (fixed
tissue) or from then on (live imaging). The rationale and
results of experiments are summarized in Table 1.
Cellular resolution of the pSCAT3 probe
In previous studies with pSCAT3, it was possible to ex-
ploit the quantitative nature of FRET for obtaining infor-
mation about the site(s) of cellular localization of
cCasp3. This was done by expressing the ratio of the
emissions of the two FRET fluorophores in a pseudoco-
lor scale [24]. We have used here a similar approach and
a logarithmic pseudocolor RGB scale to express the
value of ECFPem/Venusem (Fig. 1d and g). Using this
scale, the cellular regions where Casp3 activity was high
appeared in red, whereas areas of low activity were blue.
Figure 1d and G are exemplificative pseudocolor images
of four CGCs with an intact morphology and different
levels of activation of Casp3. Notably, in all the four cells
the nucleus displayed high Casp3 activity, but there were
also spots of intense activation within the cellular pro-
cesses in one of these cells (Fig. 1g). These observations
were in full accord with the demonstration that, after
proteolytic activation and the recognition of its substrate
protein(s), Casp3 translocates into the nucleus to trigger
cellular demolition [25]. The level of resolution of the
probe was so precise that also individual axons could be
imaged, and the well-known different phases of CGC
axonogenesis [22] were easily recognized.
By the use of ICC and a specific antibody directed
against cCasp3, we have previously shown in mouse [11]
and rabbit [16] that, once activated, the enzyme can
localize to both the cytoplasm and the nucleus of CGCs.
However, the low resolution of enzyme ICC did not
allow to easily discriminating the cellular compartment
of Casp3 localization: precipitation of 3, 3′ diaminoben-
zidine into the cytoplasm often completely obscured the
nucleus, impeding its proper observation [16], and only
slight improvements were achieved by immunofluores-
cence and combined DAPI nuclear staining [11]. Yet,
this information was merely qualitative and a correct in-
terpretation of results remained difficult.
FRET efficiency (FRETeff) of the pSCAT3 probe and
accuracy of FRET measurements in OCCs
For FRET to occur, a pair formed by a donor and an ac-
ceptor molecule is required. The donor fluorescent mol-
ecule is then excited and, if the acceptor molecule is
close enough to it, part of its emitted fluorescent light is
transferred to the acceptor. Thus, FRET has become in-
creasingly important in cell biology for its ability to
measure the distance between molecules on a scale of a
few nanometers that is far below the resolution of op-
tical fluorescence microscopes [26]. However, to cor-
rectly interpret and validate FRET experiments it is
important to first establish their degree of accuracy.
In the pSCAT3 FRET probes, the donor (ECFP) and the
acceptor (Venus) are genetically engineered into the cell.
The original studies conducted with these probes have
well depicted the space-time dynamics of the activation of
Casp3 in isolated cells [24]. Subsequent studies analyzed
the time course of apoptosis in different organs of a rela-
tively simple organism such is Drosophila [27, 28]. Im-
aging the more complex mammalian nervous system in
organotypic cultures poses additional problems [29].
Therefore, we first established whether the pSCAT3 vec-
tor was effectively transfected and functional in OCCs.
FRET efficiency (FRETeff ) is commonly used to assess
the functionality of a FRET probe inside living cells [30].
In a preliminary set of experiments, we have calculated
the theoretical range of variability of FRETeff in OCCs,
to establish a dynamic range of work for a correct inter-
pretation of subsequent studies. Due to its molecular na-
ture, the functional FRET probe (pSCAT3-DEVD) is
sensitive to any Casp3 active inside the cell that cleaves
its consensus sequence DEVD, impeding FRET to occur.
Therefore, calibrating experiments were carried out with
the control probe pSCAT3-DEVG, which is insensitive
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to Casp3 activity as donor and acceptor cannot be sepa-
rated by the proteolytic activity of the protease (Table 1:
experiments #1 and 3): after transfection, fluorescence
emissions of the donor (ECFPem) and of the acceptor
(Venusem) were measured before and after bleaching of
the acceptor. FRETeff was then calculated as indicated in
Methods and in Additional file 1. The ratio of ECFPem
and Venusem (ECFPem/Venusem - in gray scale) was
significantly increased after bleaching (Fig. 2a and
Additional file 1), with a statistically significant variation
Fig. 1 Visualization of Casp3 activation in fixed OCCs after biolistic transfection. a Low magnification image of a double-transfected OCC
(pSCAT3-DEVD + pHcRed1-C1) after excitation with the 588 nm argon laser line. HcRed1 expression permits an easy visualization, localization, and
identification of successfully transfected cells. The red-dotted line indicates the border of the culture. b-g Exemplificative images of two CGCs in
the IGL (b-d) and two CGCs (e-g) in the EGL after pSCAT3-DEVD transfection showing the emissions of the FRET pair at 475 nm (ECFP) and
530 nm (Venus). The cell at right in b-d is a CGC in the vertical bipolar stage of migration and displays a well visible axon (asterisk) that bifurcates to
give origin to a parallel fiber. The two cells in e-g are CGCs at the horizontal bipolar stage of migration. The cell at right displays some enlargements of
its processes with high Casp3 activity (arrowheads). Note that to better show the distribution of ECFP and Venus images are taken at different laser
excitation powers. As an example, the true fluorochrome emissions during FRET recording are shown in black and white in the inserts of panels b and
c. In d and g cells are imaged in pseudocolor using a logarithmic scale to display the ECFPem/Venusem ratio. Note the cellular resolution of the FRET
probe. h Combined ICC for the marker NeuN (green channel) and biolistic transfection with pHcRed1-Surv (red channel) shows two transfected CGCs in
the IGL. Both cells are in the vertical bipolar stage and their axons have been labeled by the asterisks. Image has been modified and reproduced with
permission from [29]. i-k Combined ICC for cCasp3 (red channel) and biolistic transfection with pSCAT3-DEVD (green channel) after induction of apoptosis
with 1 mM NMDA for 48 h shows several cCasp3 immunoreactive cells. The pattern of cellular localization of the 17/19 kDa fragment of the protease is
different among cells, one of which (arrow) displays a highly condensed cCasp3 positive nucleus. The larger cell transfected with pSCAT3-DEVD displays
cytoplasmic cCasp3 immunoreactivity, but the nucleus (arrowhead) is negative. Abbreviations: cCasp3 = cleaved caspase 3; CGC = cerebellar granule cell;
ECFP = enhanced cyan fluorescent protein; EGL = external granular layer of forming cerebellar cortex; IGL = internal granular layer of forming cerebellar
cortex; NeuN= nuclear nuclei antigen; NMDA=N-methyl-D-aspartate; Surv = survivin; Venus =mutated yellow fluorescent protein. Scale bars: A = 500 μm;
b-k: 10 μm
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Table 1 List of experiments, their rationale and main results
Exp # Culture conditions Transfection protocol Treatment(s) Experiment rationale
Main results
1 • Medium 1
(horse serum) – 4 DIV
• Transfection
• Medium 1
(horse serum) – 2 DIV
• FRET on fixed OCCs
Single
pcDNA-SCAT3 DEVG
(FRET control probe)
None • Assessment of theoretical probe efficiency by
acceptor photobleaching
• Exp #2 control: confirmation that cellular caspase 3
cannot cleave the mutated DEVG sequence
• FRETeff can be measured in OCCs
2 Single
pcDNA-SCAT3 DEVD
(FRET probe)
None • Calculation of ECFPem/Venusem in serum-containing
medium to measure basal caspase 3 activation
• Caspase 3 is constitutively active in CGCs
• Presence of serum reduces basal ECFPem/Venusem
(means that caspase 3 activity is reduced)
3 • Medium 1
(horse serum) – 4 DIV
• Transfection
• Medium 2
(Neurobasal) – 2 DIV
• FRET on fixed OCCs
Single
pcDNA-SCAT3 DEVG
(FRET control probe)
None • Assessment of theoretical probe efficiency by
acceptor photobleaching
• Exp #4 control: confirmation that cellular caspase 3
cannot cleave the mutated DEVG sequence
• FRETeff can be measured in OCCs
4 Single
pcDNA-SCAT3 DEVD
(FRET probe)
None • Assessment of ECFPem/Venusem in serum-free
medium to measure basal caspase 3 activation
• Caspase 3 is constitutively active in CGCs
5 • Medium 1
(horse serum) – 4 DIV
• Transfection
• Medium 1
(horse serum) – 2 DIV
• FRET on fixed OCCs
Double
pcDNA-SCAT3 DEVG
(FRET control probe) +
Casp3 shRNA control clone
None • Negative control for caspase 3 RNAi
• ECFPem/Venusem after transfection with FRET control
probe is not modified by co-transfected control
shRNA clone
6 Multiple
pcDNA-SCAT3 DEVG
(FRET control probe) +
Casp3 shRNA clones 1–4
None • Negative control for caspase 3 RNAi
• ECFPem/Venusem after transfection with FRET control
probe is not modified by co-transfected Casp3
shRNA clones
7 • Medium 1
(horse serum) – 4 DIV
• Transfection
• Medium 1
(horse serum) – 2 DIV
• FRET on fixed OCCs
Double
pcDNA-SCAT3 DEVD
(FRET probe) +
Casp3 shRNA control clone
None • Negative control for caspase 3 RNAi
• ECFPem/Venusem after transfection with FRET probe is
not modified by co-transfected control shRNA clone
8 Multiple
pcDNA-SCAT3 DEVD
(FRET probe) +
Casp3 shRNA clones 1–4
None • Demonstration of probe specificity by caspase 3 RNAi
• ECFPem/Venusem after transfection with FRET probe is
reduced by co-transfected Casp3 shRNA clones
• Constitutively active caspase 3 can be effectively
silenced by RNAi
9 • Medium 1
(horse serum) – 4 DIV
• Transfection
• Medium 1
(horse serum) – 2 DIV
• FRET on fixed OCCs
Single
pcDNA-SCAT3 DEVG
(FRET control probe)
Ac-DEVD-CMK
100 μM
• Negative control for caspase 3 inhibition
• ECFPem/Venusem after transfection with
FRET control probe is not modified in
the presence of caspase 3 inhibitor
10 Single
pcDNA-SCAT3 DEVD
(FRET probe)
Ac-DEVD-CMK
100 μM
• Demonstration of probe specificity by specific
inhibition of caspase 3
• ECFPem/Venusem after transfection with FRET probe is
reduced by caspase 3 inhibitor
• Constitutively active caspase 3 can be effectively
inhibited by Ac-DEVD-CMK
11 • Medium 1
(horse serum) – 4 DIV
• Transfection
• Medium 2
(Neurobasal) – 2 DIV
• FRET on fixed OCCs
Double
pcDNA-SCAT3 DEVD
(FRET probe) + pHcRed1-C1
None • Method control: a) Evaluation of co-transfection
efficiency; b) Evaluation of possible interferences of
Red1-C1 fluorescence with FRET
• Further morphological identification of transfected cells
• Exp #12 control
• a) Co-transfection rate is 100 %; b) Red1-C1 does not
interfere with FRET
• Confirmation of Exp #3: caspase 3 is constitutively
active in CGCs
• Transfected cells are for the most CGCs
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from 0.55 ± 0.06 (pre-bleach) to 1.10 ± 0.10 (post-bleach)
(n. cells =12, t-Test: P = 0.0001). Remarkably, it was cal-
culated that the ECFPem/Venusem normalized value
changed from 0.43 to 1.11 in HeLa cells transfected with
pSCAT3-DEVD and challenged with tumor necrosis fac-
tor α-cycloheximide, a strong activator of Casp3 [24].
Therefore, acceptor photobleaching experiments con-
firmed that the probe was sufficiently transcribed also into
an organotypic context and herein worked with compar-
able dynamic range to that observed in isolated cells, as
the pre-bleaching condition mimicked a healthy cell in
which Casp3 was inactive, whereas the post-bleaching
condition simulated an apoptotic cell where cCasp3
cleaved the ECFP/Venus pair.
The mean value of FRETeff in our experiments was
0.22 ± 0.02 (Additional file 1). In discussing this figure,
one should consider how FRETeff was calculated [31, 32]
and the type and nature of the FRET probe. For the sake
of brevity, we have discussed these two issues in
Additional file 2 where we also provided quantitative
data and relevant references for comparative purposes.
Casp3 is constitutively active in CGCs and activity is not
significantly affected by culture conditions
In experiments #1–4 we have measured ECFPem/Venusem
in CGCs transfected with pSCAT3-DEVG (control) or
pSCAT3-DEVD in the absence or presence of serum in
culture medium. We wanted to establish whether or not
Casp3 was active in our OCCs and if serum had an effect
- if any - on the level of Casp3 activity. The mean ratio of
the emissions of two fluorophores after pSCAT3-DEVD
transfection was significantly higher of that recorded in
cells transfected with pSCAT3-DEVG independent from
serum [serum-free medium: pSCAT3-DEVD 0.80 ± 0.07;
Table 1 List of experiments, their rationale and main results (Continued)
12 Double
pcDNA-SCAT3 DEVD
(FRET probe) +
pHcRed1-C1-Surv
None • Evaluation of the effects of survivin overexpression on
basal levels of caspase 3 activation
• Evaluation of the effect of survivin on cell survival
• Survivin reduces basal caspase 3 activity
• Survivin promotes cell survival
13 • Medium 1
(horse serum) – 4 DIV
•Transfection
• Medium 1
(horse serum) – 2 DIV
• FRET on fixed OCCs
Double
pcDNA-SCAT3 DEVD
(FRET probe) +
pHcRed1-C1
None • Method control: a) Evaluation of co-transfection effi-
ciency; b) Evaluation of possible interferences of Red1-
C1 fluorescence with FRET
• Further morphological identification of transfected
cells
• Exp. #14 control
• a) Co-transfection rate is 100 %; b) Red1-C1 does not
interfere with FRET
• Confirmation of Exp #4: caspase 3 is constitutively
active in CGCs
• Transfected cells are for the most CGCs
14 Double
pcDNA-SCAT3 DEVD
(FRET probe) +
pHcRed1-C1-Surv
None • Evaluation of the effects of survivin overexpression on
basal levels of caspase 3 activation
• Evaluation of the effect of survivin on cell survival
• Survivin reduces caspase 3 activity
• Survivin promotes cell survival
15 • Medium 1
(horse serum) – 4 DIV
• Transfection
• Medium 2
(Neurobasal) – 2 DIV
• FRET on fixed OCCs
Single
pcDNA-SCAT3 DEVG
(control probe) or
pcDNA-SCAT3 DEVD
(FRET probe)
• 25 mM KCl
• 1 mM NMDA
• 1 mM KA
• 100–200 μM A23187
• 50 μM–25 mM H2O2
• Measurement of caspase 3 activity after induction of
apoptosis
• A subpopulation of CGCs is insensitive to apoptosis
induction and does not display changes in
ECFPem/Venusem
• Other cells display signs of sufferance
16 • Medium 1
(horse serum) – 4 DIV
• Transfection
• Medium 2
(Neurobasal) – 1 DIV
• FRET on alive OCCs
Single
pcDNA-SCAT3 DEVD
(FRET probe)
• 60 mM KCl
• 100 mM H2O2
• Real time monitoring of caspase 3 in basal conditions
• Measurement of caspase 3 activity after depolarization
or oxidative stress
• Caspase 3 activity can be measured in real time
experiments
• Increase of ECFPem/Venusem after K
+ depolarization
but not cell death
• Only tendency to increase of ECFPem/Venusem after
oxidative stress. Reduction in the number of
transfected cells
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Fig. 2 FRET measurements of Casp3 activity in fixed OCCs and specificity controls. a calculation of FRETeff of the SCAT3 probes by acceptor
photobleaching (experiment #3). There is a statistically significant difference in the ECFPem/Venusem ratio before and after photobleaching of pSCAT3-
DEVG. The mean value of FRETeff was 0.22 ± 0.02 (see text and Additional file 1 for further information). b A comparison of the ECFPem/Venusem mean
values after transfection with pSCAT3-DEVD (FRET probe) or pSCAT3-DEVG (control probe) shows a reduction of about 56 % in ECFPem/Venusem in cells
transfected with the control probe. As in the control probe cellular Casp3 cannot cleave the FRET pair, this experiment demonstrates that the enzyme is
constitutively active in CGCs in the absence of any pharmacological treatment. After transfection, OCCs were maintained in medium 2, containing
Neurobasal and B27 supplement. c Specificity of the pSCAT3-DEVD probe for Casp3 is demonstrated after RNAi and Ac-DEVD-CMK inhibition. After
multiple transfection with pSCAT3-DEVD and the mix of the four shRNA plasmids targeting the Casp3 gene or with pSCAT3-DEVD in the presence of the
caspase inhibitor Ac-DEVD-CMK (100 μM) there is a significant reduction in the mean value of ECFPem/Venusem in comparison to that measured from OCCs
transfected with pSCAT3-DEVD alone (pastel blue bars). There are notably no differences in mean values of ECFPem/Venusem when the pSCAT3-DEVG
control probe was employed (blue bars), with the exception of OCCs transfected with a combination of pSCAT3-DEVG and the RNAi control clone
[pSCAT3-DEVG 0.33 ± 0.01 (294 cells); pSCAT3-DEVG + RNAi control 0.27 ± 0.02 (100 cells); P= 0.01]. This result is somewhat puzzling as pSCAT3-DEVG is
insensitive to Casp3 cleavage. It is also worth noting that after co-transfection with pSCAT3-DEVD + RNAi control values of ECFPem/Venusem displayed
higher variance (0.21) and, consequently, SEM was much higher (0.15 – see bars in graph) than in all other tested conditions. To explain these data we can
only speculate that transfection with a Casp3-unrelated RNAi control clone of unknown specificity (such as that provided by manufacturer) may somehow
interfere with protein synthesis machinery in cells. d TCD after RNAi and Ac-DEVD-CMK inhibition of Casp3. There is a statistically significant increase of TCD
after multiple transfection with shRNA plasmids that epigenetically inhibit the casp3 gene together with pSCAT3-DEVD (pSCAT3-DEVD 13.13 ± 1.80, n. cells
= 584; pSCAT3-DEVD+ RNAi 33.89 ± 4.09, n. cells = 840; P= 0.000926) or pSCAT3-DEVG (pSCAT3-DEVG 18.84 ± 3.72, n. cells = 941; pSCAT3-DEVG + RNAi
27.37 ± 3.91, n. cells = 1391; P= 0.04279), but not in RNAi control experiments and after Ac-DEVD-CMK [n. cells = 213 (pSCAT3-DEVD+ RNAiCONTR), 585
(pSCAT3-DEVD+ Ac-DEVD-CMK), 133 (pSCAT3-DEVG + RNAiCONTR), 794 (pSCAT3-DEVG+ Ac-DEVD-CMK)]. In these experiments, we have counted a total of
5,841 transfected cells and measured their areas. Mean area was 165.71 ± 2.16 μ2, corresponding to a mean diameter of 15 μm for a circular object.
e Transfection with pSCAT3-DEVD or pSCAT3-DEVG demonstrates the existence of a subpopulation of CGCs resistant to induction of apoptosis by
ionotropic glutamate receptor agonists and A23187 after measurement of mean values of ECFPem/Venusem (pSCAT3-DEVD 0.59 ± 0.04; n. cells = 251;
pSCAT3-DEVD + KA 0.30 ± 0.01; n. cells = 103; pSCAT3-DEVD +NMDA 0.34 ± 0.01; n. cells = 105; pSCAT3-DEVD + KA + NMDA 0.28 ± 0.01; n. cells = 62;
pSCAT3-DEVD + A23187 0.27 ± 0.01; n. cells = 132; pSCAT3-DEVG 0.33 ± 0.01 n. cells = 294; pSCAT3-DEVG + KA 0.29 ± 0.01; n. cells = 98; pSCAT3-DEVG +
NMDA 0.33 ± 0.01; n. cells = 80; pSCAT3-DEVG + KA + NMDA 0.29 ± 0.01; n. cells = 68; pSCAT3-DEVG + A23187 0.27 ± 0.005; n. cells = 7). Error bars = SEM.
*P-value 0.05–0.01 ** P-value < 0.01–0.001 % *** P-value < 0.001 %
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n. cells = 10 and pSCAT3-DEVG 0.45 ± 0.07; n. cells = 8; t-
Test: P = 0.003 (Fig. 2b); serum: pSCAT3-DEVD 0.68 ±
0.02; n. cells = 251 and pSCAT3-DEVG 0.33 ± 0.01; n.
cells = 294; t-Test: P = 5.37974E-31]. Notably, the absence/
presence of serum did not significantly interfere with the
mean of readouts of ECFPem/Venusem after transfection
with pSCAT3-DEVD (serum-free medium: 0.80 ± 0.07 n.
cells = 10 and serum-containing medium: 0.68 ± 0.02; n.
cells = 251; t-Test P = 0.15) or pSCAT3-DEVG (serum-free
medium: 0.35 ± 0.001, n. cells = 65) and serum-containing
medium: 0.29 ± 0.005, n. cells = 79); t-Test P = 0.25].
Therefore, even when OCCs were not subjected to any ex-
perimental challenge, Casp3 was constitutively active in
individual CGCs (see also experiments #5–7 and 9 that
provided controls for RNAi and Ac-DEVD-CMK inhib-
ition of Casp3).
Using the Caspase-3 sensor™ probe, our previous stud-
ies in murine OCCs have been successful in showing the
activation of Casp3 in CGCs [11]. The probe consisted
of a fluorescent tag (EYFP) that translocated from the
cytoplasm - when Casp3 was inactive - to the cell nu-
cleus, once the enzyme was activated. However, quanti-
tative studies were made possible only in terms of
counting tagged cells with different patterns of subcellu-
lar EYFP distribution (nucleus/cytoplasm fluorescence),
and it was impossible to quantitate Casp3 activation. In-
stead, our present observations provide a quantitative
readout of Casp3 basal activation in NOND, and are in
full agreement with data reported for isolated CGCs
using the QCASP3.2 probe [15].
Specificity of the pSCAT3 probe for Casp3
Once established that FRET probes were technically
suited for slice applications and detected basal levels of
the protease in OCCs, a key issue remained to be
addresses, i.e. the specificity of the method for Casp3, as
one should not omit mentioning that the DEVD consen-
sus sequence can be also recognized by Casp7 [33, 34]. To
fully clarify this issue we have devised two sets of
experiments (Table 1, experiments #5–10 and Fig. 2c-d)
using either short-hairpin RNAs (shRNAs) to knockdown
Casp3 by means of RNA interference or Ac-DEVD-CMK,
a widely-employed inhibitor of the protease [35].
In the first set of experiments, RNAi was performed
by taking advantage of one of the most appealing
features of biolistic transfection, i.e. the possibility to
simultaneously transfect multiple cDNAs inside the cell
at known stoichiometric ratios [28]. In these experi-
ments, we have measured ECFPem/Venusem in CGCs
transfected with pSCAT3-DEVG or pSCAT3-DEVD to-
gether with a control shRNA or a mix of four different
shRNAs targeting the Casp3 gene (see also figure in
Additional file 3). In the second set of experiments we
have instead measured ECFPem/Venusem in CGCs
transfected with pSCAT3-DEVG or pSCAT3-DEVD in
the presence of 100 μM Ac-DEVD-CMK. The mean ra-
tio of the emissions of two fluorophores was significantly
lower when slices were transfected with pSCAT3-DEVD
+Casp3 shRNAs [pSCAT3-DEVD 0.59 ± 0.04; n. cells =
251 and pSCAT3-DEVD+Casp3 shRNAs 0.28 ± 0.02; n.
cells = 102); t-Test: P = 2.27714E-08]. A statistically signifi-
cant reduction of ECFPem/Venusem was also observed
after transfection with pSCAT3-DEVD in the presence of
the inhibitor (pSCAT3-DEVD 0.59 ± 0.04; n. cells = 251
and pSCAT3-DEVD+ Ac-DEVD-CMK 0.32 ± 0.01; n.
cells = 104; t-Test: P = 8.62803E-07). On the other hand,
the mean value of ECFPem/Venusem was unchanged in ex-
periments after transfection with pSCAT3-DEVD + con-
trol shRNA (pSCAT3-DEVD 0.59 ± 0.04; n. cells = 251
and pSCAT3-DEVD+ control shRNA 0.69 ± 0.15; n. cells
= 106; t-Test: P = 0.55), or in RNAi and Ac-DEVD-CMK
experiments performed with the Casp3-insensitive probe
pSCAT3-DEVG (Fig. 2c blue bars).
These experiments unequivocally proved the specifi-
city of the FRET probe for Casp3, but, as a further valid-
ation, we also decided to calculate the density of
transfected cells (TCD) and value of ECFPem/Venusem
after excitation of ECFP with a laser line at 405 nm.
As to TCD, we reasoned that successful Casp3 RNAi
should match to improved cell survival, the constitutive
activity of the protease being nullified by post-
transcriptional gene silencing. In keeping with this
assumption, we observed that, after RNAi, TCD was
increased 2.58 fold in experiments using pSCAT3-DEVD
(Fig. 2d pastel blue bars), and 1.45 fold with pSCAT3-
DEVG (Fig. 2d blue bars). Notably, the graph in Fig. 2d
also shows that transfection with the RNAi control
clone, as well as treatment with the inhibitor Ac-DEVD-
CMK yielded values of TCD not statistically different
from those after any of the two pSCAT3 probes alone.
That Ac-DEVD-CMK had no statistically significant
consequences on TCD was likely due to the fact that the
inhibitor was not specifically targeted to the transfected
cells. We did not calculate the total density of cells in
OCCs, but it is well possible that an increase occurred
in the presence of Ac-DEVD-CMK. Nonetheless, an in-
crease, if any, had not measurable consequence on trans-
fection efficiency, a fact that further validates the use of
biolistics in quantitative studies of PCD.
The use of extraction procedures was not practicable to
validate RNAi experiments. Thus, obtaining unequivocal
proof for successful transfection with shRNAs required to
employ plasmids that also encoded for GFP. In this way,
we checked for GFP expression together with ECFP/
Venus in individual cells after biolistics (see figure in
Additional file 3). To exclude artifacts due to fluorescence
bleed-through between ECFP and GFP, we also have
measured FRET after excitation of ECFP at 405 nm. The
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results of these experiments are reported in Additional file
3 and show that expression of GFP in transfected cells
was not detrimental to successful recording of FRET.
Collectively, all experiments on probe validation con-
verge to demonstrate the specificity of pSCAT3-DEVD for
Casp3. It was initially demonstrated that Casp7, which is
also able to cleave the DEVD tetrapeptide, was present at
very low levels or undetectable in the brain [25]. However,
we previously shown, by ICC and Western blotting, that a
few cells in the internal granular layer (IGL) of the form-
ing rabbit cerebellar cortex in vivo were immunoreactive
for cCasp7 but, surprisingly, not for the uncleaved pro-
caspase [16]. These results were puzzling and raised some
doubts on the specificity of the primary antibodies there
employed. In keeping with the possibility that a false posi-
tive reaction was occurring in our rabbit material, a very
recent study has excluded that Casp7 cleaved the tetra-
peptide DEVD in primary cultured rat CGCs [15]. It
should also be recalled here that cCasp7, differently from
cCasp3, does not undergo nuclear translocation [33].
Thus, besides to RNAi and Ac-DEVD-CMK experiments,
a further proof for the pSCAT3-DEVD specific recogni-
tion of Casp3 came from subcellular distribution imaging,
and led to safely conclude that pSCAT3-DEVD was spe-
cifically detecting Casp3 and not Casp7 activity in organo-
typically cultured CGCs.
Experimental induction of apoptosis demonstrates that
Casp3 does not mediate cell death in a subpopulation of
CGCs
Changes in ionic concentrations inside the cell and/or in
the extracellular milieu modulate apoptosis. The concen-
tration of intracellular Ca++ ([Ca++]i), in particular, is
crucial to trigger death, and, according to the so called
“Ca++ set-point hypothesis”, [Ca++]i is dynamically set to
values optimal for neuronal survival [36]. Numerous
molecules are able to increase [Ca++]i by different mech-
anisms. Therefore, we evaluated the effects of some of
these molecules on Casp3 activity. In experiment #15
(Table 1), OCCs were incubated under depolarizing condi-
tions with 25 mM KCl, or with N-methyl-D-aspartate
(NMDA - 1 mM), kainic acid (KA - 1 mM), NMDA+ KA
(1 mM +1 mM) or A23187 (100 μM/24 h, or 200 μM/24
or 48 h). KCl was used at 25 mM, as this extracellular K+
concentration [K+]e was found to be optimal for neuro-
protection in OCCs [21]. The concentrations employed
for glutamate receptors’ agonists and A23187 were by
far exceeding those capable to induce apoptosis, as
no differences in values of ECFPem/Venusem were
observed at lower concentrations (data not shown).
We observed morphological signs of sufferance in
OCCs after these latter treatments (Fig. 3i-l). None-
theless, after apoptosis induction we did not observe
statistically significant increases in the mean value of
ECFPem/Venusem in comparison to controls (Fig. 2e).
To further demonstrate that Casp3 was activated in
OCCs challenged with pro-apoptotic glutamate agonists,
we combined transfection with pSCAT3-DEVD with the
subsequent ICC localization of cCasp3, using a specific
antibody against the large fragment (17/19 kDa) of the acti-
vated protease. Figure 1i-k is exemplificative of the pattern
of expression of cCasp3 following treatment with 1 mM
NMDA, a pattern that is consistent with the changes in
subcellular distribution of the enzyme that follow cleavage
(see Cellular resolution of the pSCAT3 probe).
Similarly to what we have observed for Ac-DEVD-
CMK (see Specificity of the pSCAT3 probe for Casp3),
pro-apoptotic treatments had no statistically significant
effects on the mean values of TCD in comparison to
controls, in which OCCs were transfected with
pSCAT3-DEVD or pSCAT3-DEVG and maintained in
plain medium (data not shown). As we have also ob-
served that maintenance in medium 1 in the presence of
60 mM KCl after transfection resulted in a massive cell
death, with no fluorescent cells in OCCs, we believe that
experiments described in this section prove, beyond any
doubt, the existence of a subpopulation CGCs which is
resistant to Casp3-mediated cell death. We exclude that
the activity of Casp3 recorded by FRET is a technical
artifact consequent to the preparation of brain slices, as
we have previously demonstrated that, although apop-
tosis of some cerebellar cells indeed occurs immediately
after explant, the latter equilibrates to the situation in
vivo after a few DIV (specifically see Fig. 3b in [17]), and
this is the reason why, in all experiments, OCCs were
left to equilibrate for 4 DIV before transfection.
It was not surprising that 25 mM KCl did not affect
the basal levels of activation of Casp3, considering that,
as mentioned, at this [K+]e, KCl increases [Ca
++]i but
acts as a pro-survival factor in OCCs (see [21] for fur-
ther discussion). Conversely, we did not anticipate ob-
serving that some CGCs were resistant to ionotropic
glutamate receptor agonists and A23187, a mobile ion-
carrier that forms stable complexes with Ca++ ions and
thereby increases [Ca++]i. NMDA and KA are, in fact, in-
volved in glutamate excitotoxicity that follows a massive
influx of Ca++ into the cell, ultimately leading to apop-
tosis [37]. Similarly, A23187 (calcimycin) acts as a pro-
apoptotic factor and was used to modulate the [Ca++]i
and, hence, apoptosis in hippocampal slices subjected to
oxygen/glucose deprivation [38].
In brief, this set of observations demonstrates that a sub-
population of CGCs was resistant to apoptosis induced by
any of these three chemicals alone or in combination. In
keeping with this possibility, 500 μM KA only slightly in-
creased Casp3 activity in cultured CGCs, and neither Z-
VAD.fmk, a pan-caspase inhibitor, nor the more specific
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Casp3 inhibitor, Ac-DEVD-CHO, prevented KA-induced
cell death [39].
Survivin overexpression reduces the basal levels of Casp3
activation in CGCs
To additionally confirm that Casp3 was active in CGCs
and that its level of activation could be dynamically reg-
ulated, we have investigated the effects of survivin over-
expression in these neurons. Survivin belongs to the
family of inhibitors of apoptosis proteins (IAPs). It inter-
venes in the development and survival of different cellu-
lar types in virtually all tissues during embryogenesis, by
taking part into mitosis and apoptosis [40]. It has been
demonstrated that, after being translocated to the nu-
cleus, survivin indirectly interacts with Casp3 to stop
the apoptotic process [41]. The interaction with Casp3
takes place by means of a series of proteins located at
different steps along the apoptotic cascade [42]. There-
fore, we were confident that the pSCAT3-DEVD probe
would allow detecting the effect of such an interaction
and be valuable in monitoring the cellular response to a
perturbation of the balance between pro-apoptotic fac-
tors and IAPs.
To study the effects of survivin overexpression onto the
level of activity of Casp3 in individual CGCs, we first have
double-transfected OCCs with pSCAT3-DEVD +
pHcRed1-C1 to verify co-transfection efficiency, and to
evaluate possible interferences of HcRed1 fluorescence
with FRET measurements. We scanned OCCs under the
LSCFM, and we observed a 100 % co-expression (>500
cells) of the three FRPs encoded by the two plasmid
DNAs. Exemplificative images of double-transfected cells
are reported in Fig. 3. Notably, HcRed1 did not interfere
with the possibility to measure FRET (see Additional file
4), and, fortunately, it was uniformly distributed inside the
cell to well depict the fine morphology of transfected
neurons.
Then, we have compared the values of ECFPem/Venusem
in cells transfected with pSCAT3-DEVD+pHcRed1-C1 with
those measured from cells transfected with pSCAT3-DEVD
+pHcRed1-C1-survivin in the presence or absence of serum
(Table 1 experiments #11–14). Figure 4a-b shows the effect
of survivin overexpression on the mean values of ECFPem/
Venusem in the presence or absence of serum. Remarkably,
in both conditions survivin overexpression significantly de-
creased these values (with serum - pSCAT3-DEVD+
pHcRed1-C1: 0.57 ± 0.06, n. cells = 110; pSCAT3-DEVD+
pHcRed1-C1-survivin: 0.25 ± 0.02, n. cells = 133; t-Test P=
0.005; without serum - pSCAT3-DEVD+pHcRed1-C1: 0.48
± 0.04, n. cells = 88; pSCAT3-DEVD+pHcRed1-C1-survivin:
Fig. 3 Exemplificative images of the different morphologies of pSCAT3-DEVD and pHcRed1-C1-survivin double-transfected cells. a-d A CGC with the
typical vertical bipolar stage morphology in the IGL. The arrow-heads indicate the axon and its branching into the parallel fiber. e-h A presumptive
Golgi cell in the IGL can be identified as being larger and displaying a multipolar morphology. i-l Two CGCs in the IGL display the typical features of
early apoptosis: retraction of processes and a tendency to cell shrinkage. Note that to better show the distribution of ECFP and Venus as well as the cell
morphology, images are taken at different laser excitation powers. Abbreviations: CGC = cerebellar granule cell; ECFP = enhanced cyan fluorescent
protein; IGL = internal granular layer of forming cerebellar cortex; Surv = survivin. Scale bars: 10 μm
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0.27 ± 0.003, n. cells = 91; t-Test P= 0.014). We have then
used a two-way ANOVA to measure simultaneously the ef-
fects of survivin overexpression and presence/absence of
serum on ECFPem/Venusem, and to assess whether or not
there was an interaction between these two parameters (four
replicas). As expected, survivin overexpression was effective
in reducing ECFPem/Venusem (P= 1.00165E-05), whereas
presence/absence of serum was not (P= 0.33), with no inter-
action of the two parameters (P= 0.17). Therefore, survivin
overexpression reduced the level of Casp3 activation in
CGCs independently of culture conditions.
We have then counted TCD of HcRed1 expressing-
CGCs after transfection with pHcRed1-C1 or pHcRed1-
C1-survivin in serum-free medium, and we found it in-
creased of 2.82 fold in cells overexpressing survivin
(Fig. 4f CTR bars - pSCAT3-DEVD + pHcRed1-C1: 5.0
± 0.81, n. cells = 142; pSCAT3-DEVD + pHcRed1-C1-
survivin: 14.09 ± 1.98, n. cells = 448; t-Test P = 0.010).
From these observations we concluded that reduction of
Casp3 activity in survivin overexpressing CGCs was par-
alleled by improved survival.
In keeping with our present observations, it was sug-
gested that survivin, in addition to keeping alive the pro-
liferating progenitors cells of central neurons during
neurogenesis, also prevented the apoptotic death of
neuronal precursors and post-mitotic neurons [20], such
are CGCs in this study. In further support, survivin-
defective mice demonstrated an increased activity of
Casp3 and 9 in CNS [20, 41, 42]. Therefore, this group
of experiments not only confirmed that Casp3 was
Fig. 4 a-b Effect of survivin overexpression on the ECFPem/Venusem values in OCCs cultivated in serum-containing medium (a) or Neurobasal +
B27 supplement (b). In both culture conditions, survivin overexpression significantly reduces the constitutive activity of Casp3 in CGCs. c Survivin
overexpression results in a statistically significant increase in the intensity of 618 nm fluorescence emission (in arbitrary units) of HcRed1 (IFemHcRed1)
in CGCs transfected with pHcRed1-C1 or pHcRed1-C1-survivin. d-e Correlation between the intensity of 618 nm fluorescence emission (in arbitrary
units) of HcRed1 (IFemHcRed1) and ECFPem/Venusem in CGCs double transfected with pSCAT3-DEVD and pHcRed1-C1 (d) or pSCAT3-DEVD and
pHcRed1-C1-survivin (e). Each dot represents a transfected cell. Note that IFemHCRed1is not correlated with Casp3 activity in cells transfected with the
survivin control vector (d), whereas IFemHCRed1, and hence survivin level inside the cell (see text), is inversely correlated to Casp3 activity when CGCs
are engineered to overexpress survivin (e). f-g Effect of H2O2 oxidative stress (5 mM) on the density of CGCs (f) or on the ECFPem/Venusem value (g)
after double transfection with pSCAT3-DEVD and pHcRed1-C1, or pSCAT3-DEVD and pHcRed1-C1-survivin. Note that oxidative stress has no effect on
either the number/area of transfected cells or the ECFPem/Venusem values when the cellular levels of survivin are not genetically manipulated. Survivin
overexpression results in a statistically significant increase in cell density, and reduced, albeit not significantly, the ECFPem/Venusem values after H2O2.
Error bars = SEM. ** P-value 0.01–0.001 % *** P-value < 0.001 %
Lossi et al. Molecular Neurodegeneration  (2016) 11:34 Page 11 of 20
constitutively active in CGCs and subjected to IAP nega-
tive modulation, but also that the apoptotic intracellular
machinery was fully operational in transfected cells,
which could be rescued from death by experimentally
manipulating their survivin content, as well as by post-
transcriptionally silencing the casp3 gene by RNAi.
Quantification of HcRed1 fluorescence and its correlation
with survivin expression and Casp3 activity
As we observed that the intensity of HcRed1 fluores-
cence was higher in cells overexpressing survivin than in
control cells, we devised another set of experiments to
establish whether or not survivin somehow interfered
with plasmid transcription efficiency. In these experi-
ments, we have measured the intensity of fluorescence
(IF) emission (618 nm – arbitrary units) of the red fluor-
ophore (IFemHcRed1) encoded by pHcRed1-C1 and
pHcRed1-C1-survivin. IFemHcRed1 provides an indication
of the level of transgene expression by the cell, as it is
proportional to the amount of fluorochrome transcribed.
Our observations demonstrated a statistically significant
increase of IFemHcRed1 in survivin-overexpressing cells in
comparison to controls (Fig. 4c - pHcRed1-C1: 35.78 ±
11.19; n. cells = 58; pHcRed1-C1-survivin: 102.57 ±
10.15, n. cells = 139; t-Test P = 0.0005). We then asked
whether or not the differences in IFemHcRed1 were indeed
correlated to different levels of activation of Casp3, ra-
ther than simply reflecting a better cellular state inde-
pendent from survivin inhibition of the Casp3-mediated
apoptotic drive. Therefore, we measured IFemHcRed1 and
ECFPem/Venusem in individual double-transfected CGCs
(pHcRed1-C1, n. cells = 23; pHcRed1-C1-survivin, n.
cells = 31). We observed a significant difference in both
IFemHcRed1 and ECFPem/Venusem between pHcRed1-C1
and pHcRed1-C1-survivin transfected cells [IFemHcRed1:
40.01 ± 4.45 (pHcRed1-C1) versus 69.93 ± 10.16
(pHcRed1-C1-survivin), t-Test: P = 0.010; ECFPem/Venu-
sem: 0.17 ± 0.005 (pHcRed1-C1) versus 0.11 ± 0.007
(pHcRed1-C1-survivin), t-Test: P = 1.70132E-09]. In
these experiments (Fig. 4d, e), we also noted that
IFemHcRed1 in survivin-overexpressing cells was inversely
proportional to ECFPem/Venusem (R2 = 0.42 ± 0.07),
whereas in cells transfected with the empty vector
(pHcRed1-C1) no correlation was detectable (R2 =
0.0003 ± 0.03). Therefore, this set of observations further
confirmed that survivin negatively modulated Casp3 ac-
tivity in transfected CGCs.
Then, in the attempt to induce apoptosis, we employed
H2O2 (from 50 μM up to25 mM) in different experimental
settings. We have thus calculated TCD of HcRed1-
expressing cells (Fig. 4f) as well as ECFPem/Venusem
(Fig. 4g) after double transfection with pSCAT3-DEVD +
pHcRed1-C1 or pSCAT3-DEVD + pHcRed1-C1-survivin,
and H2O2 challenge. In these experiments we did not find
a significant difference between TCDs in control and
H2O2-treated OCCs (5 mM – 48 h) after transfection with
pHcRed1-C1 (control: 4.78 ± 0.81, n. cells = 539; H2O2:
4.25 ± 0.93, n. cells = 302; t-Test: P = 0.66). After transfec-
tion with pHcRed1-C1-survivin, TCD of HcRed1-
expressing cells challenged with H2O2 was, instead, 46 %
that in untreated controls (control: 14.09 ± 1.98, n. cells =
890); H2O2: 6.39 ± 2.19, n. cells = 203; t-Test: P = 0.020).
On the other hand, the mean ECFPem/Venusem values did
not significantly change in cells transfected with
pHcRed1-C1 (control: 0.32 ± 0.02, n. cells = 539; H2O2:
0.32 ± 0.009, n. cells = 302; t-Test: P = 0.89) or pHcRed1-
C1-survivin (control: 0.24 ± 0.018, n. cells = 890; H2O2:
0.26 ± 0.018, n. cells = 203; t-Test: P = 0.67). We have per-
formed similar experiments in pSCAT3-DEVD transfected
cells after treatment with 25 mM H2O2 for twenty-four
hours, and confirmed that H2O2 significantly reduced
TCD without affecting the mean values of ECFPem/Venu-
sem (data not shown). Notably, at these peroxide concen-
trations, OCCs displayed clear morphological alterations
(slice shrinkage, disintegration, and cellular swelling) that
were indicative of a high degree of sufferance. In agree-
ment with our findings, 50 μM H2O2 was demonstrated
to activate Casp3 in Jurkat T-lymphocytes, but to induce
Casp3-independent necrosis at higher concentrations up
to 500 μM [43]. Authors have concluded that H2O2 had
two distinct effects on cell death: it initially inhibited the
caspases and delayed apoptosis. Then, depending on the
degree of the initial oxidative stress, caspases were activated
and death was apoptotic, or caspases remained inactive and
necrosis occurred. Altogether, we interpreted this last group
of findings as a further proof for the existence of a subpopu-
lation of CGCs that were resistant to Casp3-mediated cell
death: under basal conditions, Casp3 was active in these
CGCs and they, being already committed to die, were appar-
ently insensitive to oxidative stress; on the other hand, when
cells were rescued from death by survivin they could be
killed by oxidative stress, but without intervention of Casp3.
Live imaging allows monitoring of Casp3 activity
fluctuations under basal conditions and in response to
pharmacological manipulation
As apoptosis of CGCs is known to be a very rapid
phenomenon [16], we asked whether or not it was pos-
sible to monitor Casp3 activation in individual alive cells
for an extended period of time (up to twenty-four hours -
experiment #16 in Table 1).
Figure 5a shows the trend of the values of the ECFPem/
Venusem ratio in six CGCs that, while alive, were repeatedly
photographed with a 40x lens to acquire image pairs for
subsequent FRET analysis. Despite some fluctuations, we
saw in all cells a progressive increase of ECFPem/Venusem,
in parallel with the time of permanence in culture. Com-
parison of the ECFPem/Venusem at beginning and end of
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experiment showed a statistically significant difference (t =
0: 0.55 ± 0.02; t = 24 h: 1.17 ± 0.04, n. cells = 6; t-Test P =
0.00005), and, at the end of observations, cells displayed
more or less severe morphological changes indicative of
apoptosis. To exclude that repeated laser excitations of
ECFP at 435 nm was detrimental to cell survival, and, thus,
we were recording a non-physiological artifact increase of
Casp3 activity, we have measured ECFPem/Venusem within
a twenty-four hour interval in two different groups of cells.
In this experiment, we collected FRET snapshots only at
time 0 and 24 h in group 1 cells, whereas group 2 cells were
subjected to a total of six progressive FRET measurements
as above (Fig. 5b). These observations clearly demonstrated
that the increase of Casp3 activity was an artifact.
Therefore, we have devised another series of experiments
by using a 20x lens. Positively, under these methodological
conditions the ECFPem/Venusem value displayed some de-
gree of variability, but not a constant tendency to increase
with time in parallel with multiple laser excitations
(Fig. 5c).
Having proved with reasonable certainty that low mag-
nification imaging did not significantly interfere with cell
viability even after multiple laser exposures, we have
employed the 20x lens for all subsequent observations.
These were first aimed to establishing if our approach
could permit live cell visualization of NOND. As an ex-
ample, Figure 5d-f show the fluctuations in ECFPem/
Venusem in CGCs that remained alive (Fig. 5d), displayed
Fig. 5 FRET measurements of Casp3 activity in live OCCs. a-b Repetitive imaging with a 40x lens results in an artifact increase of the ECFPem/
Venusem values recorded from the same cells in a 24-h interval. a progressive increase in the ECFPem/Venusem ratio in six CGCs monitored at
subsequent intervals up to 24 h. b comparison of the ECFPem/Venusem ratios in two groups of cells undergoing single (left - blue dots) or repeated
(right - red dots) laser excitation to capture FRET pair images. c Imaging with a 20x lens and repetitive laser excitations did not significantly alter
the ECFPem/Venusem ratio in seven CGCs that were photographed up to ten times to acquire FRET pair images. d-f Exemplificative traces of the
fluctuations in the ECFPem/Venusem ratio in healthy (d), suffering (e) or dying/dead (f) CGCs during a four-hour follow up. FRET was measured in
these eleven cells during the course of the same experiment. Cell 2 and 3 in f died soon after one hour from start, and could not be subsequently
identified when the culture was scanned for the acquisition of images at 120 m. It should be noted that live imaging can be made difficult by X-Y axis
and focus (Z axis) drifting of the sample. If in-focus images cannot be captured at all time-points, cell(s) must be discharged from subsequent analysis.
g = Effect of 60 mM KCl depolarization on the ECFPem/Venusem ratio during a three-hour follow up (see text for further explanation). h Exemplificative
traces of the fluctuations in the ECFPem/Venusem ratio during a three-hour follow up in eight CGCs challenged with 100 mM H2O2. i Lack of a statistically
significant response to 100 mM H2O2 in a subpopulation of CGCs that appeared to be resistant to oxidative stress (see text for discussion). Error bars = SEM.
* P-value 0.05–0.01 %
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clear morphological signs of sufferance (Fig. 5e), or died
(Fig. 5f) during a four-hour observation. Notably ECFPem/
Venusem remained well below 0.40 in all healthy cells,
whereas it was already quite high at beginning of experi-
ments in suffering (Fig. 5e) or dying cells (Fig. 5f, cells 2
and 3). The time course of the ECFPem/Venusem in one of
the dying cells (Fig. 5f cell 1) was particularly interesting,
as this cell appeared to be healthy when first monitored,
but reached a very high ECFPem/Venusem during the last
two hours of follow-up. We believe to have been fortunate
enough to monitor in this cell the entire process of
NOND, as the time-scale of the progressive increase in
Casp3 activity was well coincident with the length of the
process that we have calculated after labeling in vivo of
proliferating/apoptotic CGCs in a previous study [44].
In the last two experiments, we have used real time
live imaging to follow the response of CGCs to high
depolarization (60 mM KCl – Fig. 5g) or strong oxida-
tive stress (100 mM H2O2 – Fig. 5h-i). We here wanted
to exclude that the experiments where cells were moni-
tored only once, at the end of treatment and after fix-
ation, were not fully suitable to capture a quick
dynamics of response. We had taken into consideration
this possibility because, as mentioned previously, when
challenged with 60 mM KCl for 2 DIV in the course of
transfection, no FRP-expressing cells were detectable in
fixed OCCs. Not totally unexpectedly, we observed that
CGCs responded to KCl with a statistically significant
increase in the mean ECFPem/Venusem starting from one
hour after KCl challenge (Fig. 5g). In the subsequent two
hours, the level of Casp3 activity remained significantly
higher than at starting point, but did not significantly in-
creased further. It is well know that neurons in slices re-
spond to depolarizing concentrations of [K+]e with an
increase in [Ca++]i that can be easily monitored by cal-
cium imaging with LSCFM [45]. Therefore, the rise in
ECFPem/Venusem that followed 60 mM KCl was likely a
Casp3 response to an altered intracellular Ca++ homeo-
stasis. Notably, the values assumed by ECFPem/Venusem
during the exposure to 60 mM KCl were higher than
those in physiological [K+]e (5 mM) at beginning of ob-
servation, but not so high to induce cell death, at least
in the time interval of our experiments. KCl-induced rise
in [Ca++]i promoted the activation of Casp3 and caused
excessive apoptosis when rat hippocampal neurons were
subjected to a toxic insult, but this was not the case in
the absence of the toxicant [46]. Therefore, response of
CGCs to sustained hyperpolarization indicated that
these neurons have the capability, at least for a few
hours, to adjust their cCasp3 levels to be eventually es-
caping death in OCCs.
In the last set of experiments we followed the response
of CGCs to H2O2 oxidative stress during an interval of
four hours. Figure 5h shows the fluctuations Casp3
activity in eight cells challenged with 100 mM H2O2.
The mean values ECFPem/Venusem at 0, 60, 120 and
180 min are reported in Fig. 5i. After statistical analysis,
there were no significant differences at any of the time-
points monitored in the course of the experiment. These
observations excluded the possibility that a single FRET
measurement of fixed OCCs was unfitted to capturing the
quick dynamics of the apoptotic process, and further con-
firmed that a subpopulation of CGCs did not respond to
oxidative stress with Casp3-mediated cell death.
Technical advantages of the use of pSCAT3 to detect
apoptosis ex vivo
Synthesis of the fusion protein containing the FRET pair
and of other FRPs obviously needs well functional cellular
machinery. This notion reinforces the importance of data
gathered ex vivo, as it would be impossible acquiring
similar information with extraction techniques such as
Western blotting, or Casp3 enzyme assays. In addition,
the sensitivity of Western blot is quite low, and blotting
methods require obtaining protein samples from consider-
able numbers of cells [47]. Among histological techniques,
the ICC localization of active cCasp3 is considered to be
one of the most reliable methods to detect apoptosis in
tissue sections, provided that specific antibodies are avail-
able. However, also this type of approach does not allow
obtaining direct functional information on the enzyme ac-
tivity, and, even most importantly, is not amenable to ap-
plication in live cells.
Casp3 is the main executor protease in apoptosis and
its activation was considered as a major irreversible end-
step in cell death. Activation of Casp3 is indeed a late
event in PCD, but it occurs well in advance prior to sev-
eral biochemical and morphological changes of apoptosis
[48]. Since the cascade of caspases’ activation is rapid
and apoptotic cells are very quickly removed by micro-
glia [49], the statistical probability to detect cCasp3 by
ICC remains relatively low in the brain tissue during the
course of NOND. Nonetheless, we and others have been
able to localize Casp3 by ICC during post-natal cerebel-
lar development in several species of altricial mammals,
including humans [50]. However, NOND in cerebellum
is characterized by massive apoptotic phenomena that
occur along a relatively limited time-span: it was there-
fore not surprising that the number of cCasp3 immuno-
reactive cells detected in our previous studies was by far
lower than that of successfully transfected CGCs in
which Casp3 activity could be monitored here by
pSCAT3-FRET.
In discussing the advantages of the pSCAT3-FRET ap-
proach to the study of NOND, it should be mentioned
the possible alternative use of cell-penetrating peptide
probes that can be activated by caspases. In general,
probes constructed so far also use FRET, but consist of a
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non-fluorescent acceptor that, when Casp3 is inactive
inside the cell, quenches the fluorescence of donor. The
first of these probes to be developed consisted of a cell-
penetrating Tat peptide conjugated to the effector recog-
nition sequence DEVD flanked by a fluorophore (Alexa
Fluor® 647)-quencher (QSY®21) pair [51]. Once exposed
to the action of caspases, the recognition sequence is
cut, resulting in separation of the fluorophore from the
quencher and unmasking of the Alexa fluorescent signal.
A second-generation probe, prepared by the same re-
searchers, was called KcapQ, as it consisted of the recog-
nition sequence KKKRKV, which is common to a group
of effector caspases [13]. In HeLa cells treated with
doxorubicin to induce apoptosis, KcapQ displayed in-
creased sensitivity to caspases (Casp3 > 7 > 6), greater ef-
ficiency of the fluorophore-quencher pair, and lower cell
toxicity compared to the first-generation molecule. An-
other probe of similar chemical features, TcapQ, was
employed for the detection of retinal ganglion cells’
(RGCs) apoptosis after intravitreal injection of NMDA
[12]. When TcapQ was injected before treatment with
the agonist, it was possible to observe the fluorescent
signal and its co-localization with TUNEL labeling of
fragmented DNA. More recently, others developed a
FRET pair consisting of Cy5 + QSY®21, and linked it with
the brain-targeted peptide RVG29, so that the whole
probe could cross the blood brain barrier and target the
nervous tissue with high affinity [52]. Indeed the nano-
device was functional and, after rotenone-induced apop-
tosis, accumulation of Cy5 fluorescence in several areas
of the brain could be demonstrated. Even more recently,
another Cy5/QSY®21-based probe (QCASP3.2) was de-
veloped and administered intravenously to successfully
detect apoptotic cells after permanent focal ischemia in
the mouse striatum [15].
Casp3 probes based on cell penetrating peptides are now
commercially available in kit, to be used on isolated cells.
We used one of these kits to monitor Casp3 activation in
OCCs without success, as, rather than specific labeling of
individual cells, widespread background fluorescence was
observed, most likely because it was difficult for the reagent
to effectively penetrate cerebellar slices in their thickness.
The possibility to skip transfection and to deliver a probe
with (minimally) invasive procedures is, of course, one
major advantage of the methods based on the use of cell
penetrating peptides. However, the case of RGCs was par-
ticular, as these cells and their axons are separated by the
site of injection (the vitreous body) only by the thin inner
limiting membrane of the retina. Obviously, the possibility
to image probes that cross the blood brain barrier after
intravenous administration has a great translational poten-
tial. However, the cellular resolution of these probes is, at
the moment, far lower than that obtained here: it seemed
difficult, at least from published images, to obtaining exact
information on the type(s) of cells undergoing apoptosis,
and to gather quantitative data at the single cell level. On
the other hand, pSCAT3 was already demonstrated to be
functional in embryos after in ovo transgenesis [53], and
the possibility to use the GeneGun® approach in vivo, al-
though technically demanding, is rather appealing to avoid
the labor- and time-consuming procedure of generating
new transgenic strains.
Functional significance of Casp3 activation in CGCs
An excellent comprehensive discussion of the role of apop-
tosis in cerebellar development has very recently been pub-
lished in the more general framework of resuming current
knowledge on the commitment and fate of the cerebellar
neurons [50]. In altricial mammals, CGCs are affected by
two subsequent waves of apoptotic cell death during the
course of their post-natal generation and migration [49].
The two waves, respectively, strike the neuronal progenitors
(pre-migratory neuroblasts), and the mature post-migratory
CGCs [16]. In the past, we have provided data as regarding
the possibility that the apoptotic cell death of the CGC pro-
genitors was Casp3-independent [11, 16]. Others have de-
scribed an intervention of Casp3 during the course of CGC
progenitor apoptosis, when OCCs were subjected to
insulin-deprivation [54]. Notably, based on some discrepan-
cies between the numbers of apoptotic cells after ICC or
TUNEL, these authors hypothesized that at least some
CGCs in their cultures died in a Casp3-independent
manner.
The present study uses a totally new approach to dy-
namically analyze the site(s) of Casp3 activation at cellular
and histological levels. Here we have shown that the en-
zyme is constitutively active in CGCs, and that activity
can be observed at all stages of their differentiation and
migration. We also demonstrated here that Casp3 activa-
tion does not simply follow an off-on regulation in live
neurons: this implies that quantification of Casp3 activity
is of primary importance for a correct understanding of
the role of the protease in NOND and neuropathology, as
the mere localization of cCasp3 might be confounding.
Under this perspective, it is worth mentioning that we
have previously demonstrated a post-translational upregu-
lation of Bcl2, one of the most important mammalian
anti-apoptotic proteins, as a response to extracellular/
intracellular changes of K+ and/or Ca++ in CGCs [21].
Our present findings are in line with the possibility that
CGCs, which will be successful in surviving NOND or in
antagonizing a perturbation of their ionic milieu, dynamic-
ally counteract cleavage of Casp3 via, among others, a
Bcl2-dependent mechanism.
However, the discovery that Casp3 displays a low level
of activity in a subset CGCs, and that these cells are re-
sistant to challenge with apoptosis inducers or oxidative
stressor strengthens the notion that Casp3 in neurons
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may also promote non-apoptotic functions [9, 55]. It is
thus useful recalling that we have been able to capture
here the existence of spots of intense Casp3 activity in
neuronal processes, at a developmental stage when
synapses are formed in the cerebellar cortex. This obser-
vation is compatible with the very recent demonstration
that the enzyme intervenes in the elimination of post-
synaptic structures [56], and that its deficiency results in
disrupted synaptic homeostasis [57].
Conclusions
We have described here the implementation and refine-
ment of a FRET-based methodology that is capable of
capturing the functional and histological dynamics of
Casp3 activation in individual mouse cerebellar neurons
at a cellular level of resolution. Not only this approach
has several advantages when compared to the currently
existing methodologies for monitoring neuronal apop-
tosis, but it is amenable to be combined with the experi-
mental manipulation of the apoptotic machinery inside
the cell, eventually providing quantitative results that are
fundamental for a comprehension of the role of Casp3
in live nerve cells. From the comparisons of the different
sets of our experiments, the SCAT3 probes display re-
markable uniformity in the readout of ECFPem/Venusem
under different physiological and experimental condi-
tions such in basal constitutive activity (0.50–0.80),
Casp3 RNAi, Ac-DEVD-CMK inhibition, survivin over-
expression, resistance to apoptosis inductors (0.25–0.40),
or oxidative stress-induced apoptosis (>0.80). Collect-
ively, these observations prove that the probes are very
stable and insensitive to changes in cellular environment
that could otherwise result in changes of FRETeff and,
thence, ECFPem/Venusem. Our protocol ex vivo can be
immediately applied to monitor the activity of the en-
zyme in slices from any areas of the brain and in retina,
and has the potential to be transferred in vivo.
From the present study we provide a new hypothesis
on the mechanism of regulation of Casp3 in cerebellum,
and demonstrate the existence of a subpopulation of
CGCs that does not respond to pro-apoptotic stimuli
with increased Casp3 activity. As the role of Casp3 in
the normal and pathological brain is gaining more and
more importance, we believe that our approach is of
relevance for a better comprehension of the regulation
of NOND and molecular neurodegeneration in disease.
Methods
Ethics statement
All procedures were carried out according to regulations
on experimental animal husbandry and care/welfare of the
Italian Ministry of Health and University of Turin. They
were approved by the Commission of Bioethics at the
University of Turin and the Ministerial Office in charge for
Protection of Experimental Animals. Animals were reared
in the animal house of the Department of Veterinary
Sciences, University of Turin. Housing conditions were
those provided by the DL 26/2014 (protection of experi-
mental animals). In addition, although not required by law,
we kept all animals in an enriched environment by provid-
ing them with the living conditions laid down by the EU
recommendations on the welfare of experimental animals
(Directives 2010/63/EU of the European Parliament and
22/09/10 of the European Council on protection of animals
bred for scientific purposes).
Animal manipulation and collection of tissue samples
Mice (n = 86) at post-natal day 5 (P5) were euthanized
with an overdose of sodium pentobarbital. The brain
was quickly removed and placed in ice-cooled Gey’s so-
lution (Sigma Chemicals, St. Louis, MO) supplemented
with glucose and antioxidants (for 500 mL: 50 % glucose
4.8 mL, ascorbic acid 0.05 g, sodium pyruvate 0.1 g).
The cerebellum was then isolated and immediately sec-
tioned in 400 μm parasagittal slices with a McIlwain
tissue chopper (Brinkmann Instruments, Westbury, NY),
while submerged in a drop of cooled Gey’s solution.
Preparation of OCCs
Three to five cerebellar slices were plated onto Millicell-
CM inserts (Millipore, Billerica, MA). Each insert was sub-
sequently placed inside a 35 mm Petri dish containing
1.1 mL of culture medium, and incubated at 34 ° C in 5 %
CO2 for up to 8 days in vitro (DIV). Two different culture
media (medium 1 - with horse serum; medium 2 - without
horse serum) were employed in various sets of experiments
(Table 1). Medium 1 was 50 % Eagle basal medium (BME,
Sigma Chemicals), 25 % horse serum (Gibco®, Life Tech-
nologies™, Carlsbad, CA), 25 % Hanks balanced salt solu-
tion (HBSS, Sigma Chemicals), 0.5 % glucose, 0.5 %
200 mM L-glutamine, and 1 % antibiotic/antimycotic solu-
tion. Medium 2 was 95 % Neurobasal Medium A (Gibco®),
2 % B27 supplement 50X (Gibco®), 2 % 100 mM L-glutam-
ine, and 1 % antibiotic/antimycotic solution. In all experi-
ments, immediately after explant OCCs were plated in
medium 1 and incubated for 4 DIV to allow them equili-
brating to the in vitro conditions. On the fifth day, immedi-
ately after biolistic transfection, OCCs were transferred into
fresh medium 1 or 2 according the experimental protocol.
Further details on the procedure can be found in [21].
Plasmids
The following plasmids have been used:
 FRET probes: FRET probes consisted of a functional
probe (pSCAT3-DEVD) and a control probe
(pSCAT3-DEVG). The two plasmids encode a FRET
pair consisting of ECFP as a donor, and Venus
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(a mutant form of YFP) as an acceptor, linked by
either the Casp3 recognition and cleavage sequence
DEVD or the inappropriate sequence DEVG. In the
latter, a glycine substituted for a critical aspartic acid
as the fourth residue of cleavage site renders it
insensitive to Casp3 activity. Coding is under the
control of the hCMV promoter. Excitation/emission
maxima are 435 nm/475 nm (ECFP) and 475 nm/
530 nm (Venus) [24, 58].
 Survivin probes: pHcRed1-C1, pHcRed (Clontech
Laboratories, Mountain View, CA), and pHcRed1-C1-
survivin encode for HcRed1. The protein emits in the
far red, with excitation/emission maxima at 588 nm/
618 nm. pHcRed1-C1-survivin was obtained after
insertion of the DNA sequence coding for survivin in
the MCS, fused with the C-terminal sequence of
HcRed1 [59]. HcRed1 maintains its characteristics of
fluorescence even when used as a fusion protein and
acts, therefore, as a reporter protein allowing the
localization of successfully transfected cells by means of
red fluorescence emission.
 shRNA plasmids: Casp3 RNAi experiments were
performed using a commercially available kit
(Casp3 SureSilencing shRNA Plasmids, Quiagen,
Hilden, Germany). The kit contains four different
shRNA plasmids and a negative control plasmid.
Plasmids also encode GFP as a reporter protein.
Plasmid DNAs were amplified and harvested from
competent E. coli cultures following conventional proce-
dures, and suspended in TE buffer at a stock concentra-
tion of 1 μg DNA/μL for downstream applications.
Biolistic transfection
The basic protocol for biolistic transfection was modified
from [21]. All procedures were carried out at room
temperature, unless otherwise stated. Gold particles (1 μm)
were coated with plasmid DNA as follows: in a microfuge
tube, 500 μL of a 50 mg/mL suspension of gold particles
(DNAdelTM Gold Carrier Particles – S1000d, Seashell
Technology, LLC, La Jolla, CA) were added to 330 μL bind-
ing buffer (Seashell Technology) upon vortexing, to a final
concentration of 30 mg gold/mL. After sonication, 50 μg of
plasmid DNA (single transfection), or 25 + 25 μg of two dif-
ferent plasmid DNAs (double transfection) were added, so
that the gold-to-DNA ratio (50/25 = 2 μg/mg) remained
unchanged. While vortexing, an equal volume of precipita-
tion buffer was added (380 μL for 1 μg/μL DNA stocks),
and the tube was left to stand for 3 min. In RNAi experi-
ments, gold particles were coated with the four different
shRNA plasmids or with the shRNA control plasmid to-
gether with pSCAT3-DEVD or pSCAT3-DEVG. In these
experiments, we employed a slightly higher gold-to-DNA
ratio (2.5 μg/mg) to have more gold available for coating.
The gold-to-DNA ratio was maintained constant in all dif-
ferent types of cartridges (Additional file 5).
The DNA-gold complex was then spun at 10,000-x g
in a microfuge for 10 s to pellet the DNA-coated gold
particles. After removal of the supernatant the pellet was
first resuspended in 500 μL of cold ethanol, then vor-
texed, pelleted, and again resuspended in 3.5 mL cold
ethanol. The gold suspension was briefly sonicated,
transferred into the Tubing Prep Station® (Bio-Rad,
Hercules, CA), and cartridges were prepared according
to the manufacturer’s protocol. Slices were transfected
by the Helios Gene Gun® (Bio-Rad) at an operating pres-
sure of 160 psi and by placing the barrel liner over the
target at a distance of 1.6 mm with a spacer. One single
shot was given to each culture dish. Additional details
on the procedure can be found in [60].
ICC
To identify transfected CGCs and to localize cCasp3, OCCs
shot with the Helios Gene Gun® were processed for ICC as
described elsewhere [29]. The rabbit polyclonal antibody
against NeuN (Abcam, Cambridge, UK) was used at a dilu-
tion of 1:1,500. The rabbit polyclonal antibody against the
large fragment (17/19 kDa) of activated Casp3 does not
recognize full length Casp3 or other cleaved caspases
(#9661 Cell Signaling Technology, Danvers, MA). It was
used at a dilution of 1:200.
Live imaging
A custom-made incubation chamber was used for live
imaging LSCFM of OCCs (Tokai Hit, Fujinomiya-shi,
Japan). The chamber was described in details elsewhere
[60]. It was mounted over the stage of a SP5 LSCFM
(Leica Microsystems, Wetzlar, GE), so that the OCCs
grown on the Millicell-CM insert membrane could be
directly observed at different time intervals and medium
replaced as necessary without moving the insert from
the stage. This allowed the recognition of individual cells
in serial snapshots from the same microscopic field in
long-term follow up experiments.
Monitoring caspase-3 activation by FRET
Calculation of FRET efficiency (FRETeff) of the pSCAT3 probe
FRETeff was calculated after acceptor photobleaching, by
measuring the resultant increase in donor fluorescence
after destroying the acceptor [61]. The procedure was
carried out by comparing donor fluorescence intensity in
the same cells before and after destroying the acceptor
by full-power laser excitation. After transfection with
pSCAT3-DEVG, OCCs were fixed (see below) and indi-
vidual cells subjected to bleaching by repeated excite-
ment of the Venus fluorochrome with the 514 nm laser
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at maximum power and a 63x oil lens (NA = 1.4). The
energy transfer efficiency was quantified as:
FRETeff ¼ Dpost−Dpre
 
=Dpost
Where
Dpost = fluorescence emission intensity of the donor
after acceptor photobleaching; Dpre = fluorescence emis-
sion intensity of the donor before acceptor photobleach-
ing; FRETeff is positive when Dpost >Dpre. For further
information see Additional file 1.
Fixed OCCs
Forty-eight hours after transfection, OCCs were fixed in
4 % paraformaldehyde (PFA) in 0.1 M phosphate buffer
(pH 7.4–7.6) for one hour at room temperature [29]. In
[52], for simultaneous detection of pSCAT3 ratio
changes and Casp3 activation by ICC, SCAT3+ trans-
genic embryos were fixed with 2 PFA and 0.1 % glutaral-
dehyde in phosphate-buffered saline for 20 min on ice.
We decided to avoid glutaraldehyde fixation as it gives
high auto-fluorescence, besides to having a detrimental
effect on antigenicity, and increased the % of PFA for
better morphological preservation. After several washes
in buffer, we mounted OCCs on glass slides and ob-
served them with the confocal microscope. For FRET
detection, the 458 nm excitation line from the argon ion
laser at 30 % power was used to excite ECFP. Images
were taken by the use of a 63x oil lens (NA = 1.4) or a
40x dry lens (NA = 1) with appropriate ECFP and Venus
filters. The emission filter sets used were: band-pass
BP470–500 nm, for ECFP, and long-pass LP530 nm for
Venus. A region of interest (ROI) corresponding to the
entire cell body was drawn for each CGC, and two sep-
arate 1024x1024 images of the same field were captured,
one for each of the two FRET fluorophores. All micro-
scope settings remained unchanged during capture. In
dual labeling experiments, a third 1024x1024 image was
acquired for the red channel, to record HcRed1 fluores-
cence (λ = 630 nm). See Additional file 4 for further de-
tails on this procedure, and Additional file 3 for the
procedure used to measure FRET after excitation of
ECFP with a 405 nm laser line.
Living OCCs
To measure FRET in living OCCs, 4 DIV cultures trans-
fected with probe-containing plasmids were transferred
into the incubation chamber mounted on the SP5 stage.
We subjected OCCs to pharmacological treatments (see
Table 1) and monitored them at different time intervals
up to twenty-four hours. At each monitoring point, dif-
ferent sets of digital images were acquired according to
the experimental paradigm employed (two images for
single transfection experiments, three for double
transfections), as described above. Images were taken
with a 40x water immersion lens (NA = 0.8), or a 20x
dry lens (NA = 0.5).
Statistical analysis
We performed statistical analysis on raw data, using the
Excel spreadsheet Analysis Tool Pack. Student’s t-Test
for independent groups was used when two conditions
at a time were matched after F-test for equality of two
variances. ANOVA was applied to compare data divided
in more than two groups. We reported data as means ±
SEM, with n. indicating the number of cells. For each
experimental condition, we recorded cells from at least
three different OCCs. We considered statistically signifi-
cant P values ≤0.05.
Calculation of TCD
We calculated TCD with the Image J software (https://
imagej.nih.gov/ij/). First, we photographed each cerebellar
slice in OCCs with a 5x lens under a transmitted/fluores-
cence light microscope (DM6000B, Leica) equipped with
appropriate filter combinations to detect GFP, Venus or
HcRed1. Then, we calculated the total area of each slice,
applied a threshold to isolate fluorescent cells from the
underlying background, and finally used the Count Ob-
jects command to calculate the number and areas of
transfected cells. Measurements were set to take into
consideration only objects with areas falling into the 20–
314 μ2 range. This corresponded to hypothetic circular
cells of 5–20 μM in diameter.
Drugs
A23187 (calcimycin), H2O2, NMDA, and KA were from
Sigma Chemicals. Caspase-3 inhibitor III (Ac-DEVD-
CMK) was from Santa Cruz Biotechnology, Dallas TX.
Additional files
Additional file 1: Calculation of FRET efficiency by acceptor
photobleaching. Protocol for acceptor photobleaching – Data on
acceptor photobleaching. (DOCX 29 kb)
Additional file 2: Main advantages/disadvantages of the methods
available for monitoring FRETeff at single cell level. Comparative tables
and references for FRET protocols. (DOCX 40 kb)
Additional file 3: Measurement of FRET in RNAi experiments using the
405 nm laser line. Measurement of FRET after excitation of CYFP at
405 nm to show that FRET can be successfully measured in multiple
transfected cells expressing GFP as a reporter protein for shRNA
transfection. An image of a group of multiple transfected cells is
provided. (DOCX 2651 kb)
Additional file 4: Measurement of FRET in double transfected CGCs.
Examples of the measurement of the ECFPem/Venusem ratio in six
pSCAT3-DEVD + pHcRed1-C1 double transfected cells. (DOCX 1342 kb)
Additional file 5: Preparation of cartridges for Casp3 RNAi experiments.
Protocol to prepare multiple plasmid DNA-coated gold particles for biolistic
experiments. (DOCX 18 kb)
Lossi et al. Molecular Neurodegeneration  (2016) 11:34 Page 18 of 20
Abbreviations
cCasp3: cleaved Casp3; CGCs: cerebellar granule cells; DsRed1: wild-type
Discosoma red fluorescent protein; ECFP: enhanced cyan fluorescent protein;
E-FRET: sensitized acceptor fluorescence; EYFP: enhanced yellow fluorescent
protein; FLIM-FRET: donor fluorescence lifetime; FRET: fluorescence resonance
energy transfer; FRPs: fluorescent reporter proteins; hCMV: human
cytomegalovirus; HcRed1: humanized DsRed1; HPT: hours post-transfection;
IAPs: inhibitors of apoptosis proteins; ICC: immunocytochemistry;
LSCFM: laser scanning confocal fluorescence microscopy; NA: numerical
aperture; NMDA: N-methyl-D-aspartate; NOND: naturally occurring neuronal
death; OCCs: organotypic cerebellar cultures; p: plasmid; PCD: programmed
cell death; RGCs: retinal ganglion cells; RNAi: RNA interference; ROI: region of
interest; sh: short hairpin; TCD: transfected cell density.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LL conceived the study, participated in its design and coordination,
performed ICC, wide-field microscopy studies and TCD analysis, helped to
draft the manuscript. CC performed LSCFM, FRET measurements on fixed
tissues, helped to prepare OCCs, and to perform ICC and statistics. SA
performed LSCFM, FRET measurements on fixed and live tissues, and initial
statistical analysis. AM conceived the study, participated in its design and
coordination, performed RNAi and inhibitor experiments, critically revised
statistical analysis, and drafted the manuscript. All authors have been
involved in drafting the manuscript or revising it critically for important
intellectual content, read and approved the final manuscript.
Acknowledgements
We are greatly indebted to Prof. Masayuki Miura for kindly providing us with the
SCAT3-DEVD and SCAT3-DEVG probes and for useful comments and suggestions
about this work. We also wish to thank Dr. Rachel Altura for her kind gift of the
HcRed1-C1-survivin plasmid. This work was supported by local grants from the
University of Turin.
Received: 18 August 2015 Accepted: 22 April 2016
References
1. Lossi L, Castagna C, Merighi A. Neuronal cell death: an overview of its
different forms in central and peripheral neurons. In: Lossi L, Merighi A,
editors. Neuronal Cell Death. New York: Springer; 2015. p. 1–18.
2. Hamburger V, Oppenheim RW. Naturally occurring neuronal death in
vertebrates: neuroembryology. Boston: Birkhäuser; 1990. p. 126–42.
3. Yuan J. Molecular control of life and death. Curr Opin Cell Biol. 1995;7:211–4.
4. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;407:802–9.
5. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312–6.
6. Cryns V, Yuan J. Proteases to die for. Genes Dev. 1998;12:1551–70.
7. Blatt NB, Glick GD. Signaling pathways and effector mechanisms pre-
programmed cell death. Bioorg Med Chem. 2001;9:1371–84.
8. Adams JM, Cory S. Apoptosomes: engines for caspase activation. Curr Opin
Cell Biol. 2002;14:715–20.
9. D’Amelio M, Cavallucci V, Cecconi F. Neuronal caspase-3 signaling: not only
cell death. Cell Death Differ. 2010;17:1104–14.
10. Lossi L, Mioletti S, Aimar P, Bruno R, Merighi A. In vivo analysis of cell
proliferation and apoptosis in the CNS. In: Merighi A, Carmignoto G, editors.
Cellular and Molecular Methods in Neuroscience Research. New York:
Springer Verlag; 2002. p. 235–58.
11. Lossi L, Tamagno I, Merighi A. Molecular morphology of neuronal apoptosis:
activation of caspase 3 during postnatal development of mouse cerebellar
cortex. J Mol Histol. 2004;35:621–9.
12. Barnett EM, Zhang X, Maxwell D, Chang Q, Piwnica-Worms D. Single-cell
imaging of retinal ganglion cell apoptosis with a cell-penetrating,
activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci
USA. 2009;106:9391–6.
13. Maxwell D, Chang Q, Zhang X, Barnett EM, Piwnica-Worms D. An improved
cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for
apoptosis imaging. Bioconjug Chem. 2009;20:702–9.
14. Liu Y, Hu Y, Guo Y, Ma H, Li J, Jiang C. Targeted imaging of activated
caspase-3 in the central nervous system by a dual functional nano-device.
J Control Release. 2012;163:203–10.
15. Jolivel V, Arthaud S, Botia B, Portal C, Delest B, Clavé G, et al. Biochemical
characterization of a caspase-3 Far-red fluorescent probe for non-invasive
optical imaging of neuronal apoptosis. J Mol Neurosci. 2014;54:451–62.
16. Lossi L, Gambino G, Mioletti S, Merighi A. In vivo analysis reveals different
apoptotic pathways in pre- and post-migratory cerebellar granule cells of
rabbit. J Neurobiol. 2004;60:437–52.
17. Lossi L, Alasia S, Salio C, Merighi A. Cell death and proliferation in acute slices
and organotypic cultures of mammalian CNS. Prog Neurobiol. 2009;88:221–45.
18. Lakowicz JR, Gryczynski II, Gryczynski Z. High throughput screening with
multiphoton excitation. J Biomol Screen. 1999;4:355–62.
19. Zadran S, Standley S, Wong K, Otiniano E, Amighi A, Baudry M. Fluorescence
resonance energy transfer (FRET)-based biosensors: visualizing cellular
dynamics and bioenergetics. Appl Microbiol Biotechnol. 2012;96:895–902.
20. Jiang Y, De BA, Caldas H, Fangusaro J, Hayes J, Conway EM, et al. Essential
role for survivin in early brain development. J Neurosci. 2005;25:6962–70.
21. Lossi L, Gambino G, Ferrini F, Alasia S, Merighi A. Posttranslational regulation
of BCL2 levels in cerebellar granule cells: a mechanism of neuronal survival.
Dev Neurobiol. 2009;69:855–70.
22. Altman J, Bayer SA. Development of the cerebellar system in relation to its
evolution, structure and functions. Boca Raton: CRC Press; 1997.
23. Weyer A, Schilling K. Developmental and cell type-specific expression of the
neuronal marker NeuN in the murine cerebellum. J Neurosci Res. 2003;73:400–9.
24. Takemoto K, Nagai T, Miyawaki A, Miura M. Spatio-temporal activation of
caspase revealed by indicator that is insensitive to environmental effects.
J Cell Biol. 2003;160:235–43.
25. Kamada S, Kikkawa U, Tsujimoto Y, Hunter T. Nuclear translocation of
caspase-3 is dependent on its proteolytic activation and recognition of a
substrate-like protein(s). J Biol Chem. 2005;280:857–60.
26. Stryer L, Haugland RP. Energy transfer: a spectroscopic ruler. Proc Natl Acad
Sci USA. 1967;58:719–26.
27. Takemoto K, Kuranaga E, Tonoki A, Nagai T, Miyawaki A, Miura M. Local
initiation of caspase activation in Drosophila salivary gland programmed cell
death in vivo. Proc Natl Acad Sci USA. 2007;104:13367–72.
28. Kuranaga E, Matsunuma T, Kanuka H, Takemoto K, Koto A, Kimura K, et al.
Apoptosis controls the speed of looping morphogenesis in Drosophila male
terminalia. Development. 2011;138:1493–9.
29. Alasia S, Merighi A, Lossi L. Transfection techniques and combined
immunocytochemistry in cell cultures and organotypic slices. In: Merighi A,
Lossi L, editors. Immunocytochemistry and Related Techniques. New York:
Springer; 2015. p. 329–55.
30. Koushik SV, Chen H, Thaler C, Puhl III HL, Vogel SS. Cerulean, Venus, and
VenusY67C FRET reference standards. Biophys J. 2006;91:L99–L101.
31. Gordon GW, Berry G, Liang XH, Levine B, Herman B. Quantitative
fluorescence resonance energy transfer measurements using fluorescence
microscopy. Biophys J. 1998;74:2702–13.
32. Becker W, Bergmann A, Hink MA, Konig K, Benndorf K, Biskup C.
Fluorescence lifetime imaging by time-correlated single-photon counting.
Microsc Res Tech. 2004;63:58–66.
33. Juan TS, McNiece IK, Argento JM, Jenkins NA, Gilbert DJ, Copeland NG, et al.
Identification and mapping of Casp7, a cysteine protease resembling CPP32
beta, interleukin-1 beta converting enzyme, and CED-3. Genomics.
1997;40:86–93.
34. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1–16.
35. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M,
et al. Identification and inhibition of the ICE/CED-3 protease necessary for
mammalian apoptosis. Nature. 1995;376:37–43.
36. Johnson Jr EM, Koike T, Franklin J. A “calcium set-point hypothesis” of
neuronal dependence on neurotrophic factor. Exp Neurol. 1992;115:163–6.
37. Arundine M, Tymianski M. Molecular mechanisms of calcium-dependent
neurodegeneration in excitotoxicity. Cell Calcium. 2003;34:325–37.
38. Bickler PE, Fahlman CS. Moderate increases in intracellular calcium activate
neuroprotective signals in hippocampal neurons. Neuroscience. 2004;127:673–83.
39. Verdaguer E, Garcia-Jordá E, Jiménez A, Stranges A, Sureda FX, Canudas AM,
et al. Kainic acid-induced neuronal cell death in cerebellar granule cells is
not prevented by caspase inhibitors. Br J Pharmacol. 2002;135:1297–307.
40. Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T, Noel JP. Structure of the
human anti-apoptotic protein survivin reveals a dimeric arrangement.
Nat Struct Biol. 2000;7:602–8.
Lossi et al. Molecular Neurodegeneration  (2016) 11:34 Page 19 of 20
41. Altieri DC. Survivin and IAP proteins in cell-death mechanisms. Biochem J.
2010;430:199–205.
42. Altieri DC. Survivin and apoptosis control. Adv Cancer Res. 2003;88:31–52.
43. Hampton MB, Orrenius S. Dual regulation of caspase activity by hydrogen
peroxide: implications for apoptosis. FEBS Lett. 1997;414:552–6.
44. Lossi L, Mioletti S, Merighi A. Synapse-independent and synapse-dependent
apoptosis of cerebellar granule cells in postnatal rabbits occur at two
subsequent but partly overlapping developmental stages. Neuroscience.
2002;112:509–23.
45. Pasti L, Volterra A, Pozzan T, Carmignoto G. Intracellular calcium oscillations
in astrocytes: a highly plastic, bidirectional form of communication between
neurons and astrocytes in situ. J Neurosci. 1997;17:7817–30.
46. Yang J, Liu Q, Wu S, Xi Q, Cai Y. Effects of lanthanum chloride on glutamate
level, intracellular calcium concentration and caspases expression in the rat
hippocampus. Biometals. 2013;26:43–59.
47. Koike-Kuroda Y, Kakeyama M, Fujimaki H, Tsukahara S. Use of live imaging
analysis for evaluation of cytotoxic chemicals that induce apoptotic cell
death. Toxicol In Vitro. 2010;24:2012–20.
48. Rao L, White E. Bcl-2 and the ICE family of apoptotic regulators: making a
connection. Curr Opin Genet Dev. 1997;7:52–8.
49. Lossi L, Merighi A. In vivo cellular and molecular mechanisms of neuronal
apoptosis in the mammalian CNS. Progr Neurobiol. 2003;69:287–312.
50. Marzban H, Del Bigio MR, Alizadeh J, Ghavami S, Zachariah RM, Rastegar M.
Cellular commitment in the developing cerebellum. Front Cell Neurosci.
2015;8:450. doi:10.3389/fncel.2014.00450. eCollection@2014;450.
51. Bullok K, Piwnica-Worms D. Synthesis and characterization of a small,
membrane-permeant, caspase-activatable far-red fluorescent peptide for
imaging apoptosis. J Med Chem. 2005;48:5404–7.
52. Yamaguchi Y, Shinotsuka N, Nonomura K, Takemoto K, Kuida K, Yosida H, et
al. Live imaging of apoptosis in a novel transgenic mouse highlights its role
in neural tube closure. J Cell Biol. 2011;195:1047–60.
53. Smolewski P, Robak T. Inhibitors of apoptosis proteins (IAPs) as potential
molecular targets for therapy of hematological malignancies. Curr Mol Med.
2011;11:633–49.
54. Tanaka M, Momoi T, Marunouchi T. In situ detection of activated caspase-3
in apoptotic granule neurons in the developing cerebellum in slice cultures
and in vivo. Brain Res Dev Brain Res. 2000;121:223–8.
55. D’Amelio M, Sheng M, Cecconi F. Caspase-3 in the central nervous system:
beyond apoptosis. Trends Neurosci. 2012;35:700–9.
56. Wang JY, Chen F, Fu XQ, Ding CS, Zhou L, Zhang XH, et al. Caspase-3
cleavage of dishevelled induces elimination of postsynaptic structures. Dev
Cell. 2014;28:670–84.
57. Lo SC, Wang Y, Weber M, Larson JL, Scearce-Levie K, Sheng M. Caspase-3
deficiency results in disrupted synaptic homeostasis and impaired attention
control. J Neurosci. 2015;35:2118–32.
58. Wu Y, Xing D, Luo S, Tang Y, Chen Q. Detection of caspase-3 activation in
single cells by fluorescence resonance energy transfer during
photodynamic therapy induced apoptosis. Cancer Lett. 2006;235:239–47.
59. Caldas H, Jiang Y, Holloway MP, Fangusaro J, Mahotka C, Conway EM, et al.
Survivin splice variants regulate the balance between proliferation and cell
death. Oncogene. 2005;24:1994–2007.
60. Alasia S, Cocito C, Merighi A, Lossi L. Real time visualization of caspase-3
activation by fluorescence resonance energy transfer (FRET). In: Lossi L,
Merighi A, editors. Neuronal cell death. New York: Humana Press/Springer
Science + Business Media; 2015; p. 99–114.
61. Pelet S, Previte MJ, Kim D, Kim KH, Su TT, So PT. Frequency domain lifetime
and spectral imaging microscopy. Microsc Res Tech. 2006;69:861–74.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Lossi et al. Molecular Neurodegeneration  (2016) 11:34 Page 20 of 20
